Literature DB >> 20740088

Successful treatment with intravenous immunoglobulin of acute flaccid paralysis caused by west nile virus.

Mohammad Sami Walid1, Fade Aziz Mahmoud.   

Abstract

West Nile virus (WNV) is one of the leading causes of insect-borne encephalitis and acute flaccid paralysis in the US. Acute flaccid paralysis is a potentially serious illness, which manifests itself as a Guillain-Barré-like syndrome with generalized weakness and shortness of breath. We report a case involving a patient who presented with acute flaccid paralysis due to WNV infection and was successfully treated with intravenous immunoglobulin from Israeli donors.

Entities:  

Year:  2009        PMID： 20740088      PMCID： PMC2911811          DOI： 10.7812/TPP/09-028

Source DB:  PubMed          Journal:  Perm J        ISSN： 1552-5767


  14 in total

1.  The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis.

Authors:  Michael Haley; Avi S Retter; Daniel Fowler; Jaun Gea-Banacloche; Naomi P O'Grady
Journal:  Clin Infect Dis       Date:  2003-08-27       Impact factor: 9.079

Review 2.  Failure of interferon alpha-2b in a patient with West Nile virus meningoencephalitis and acute flaccid paralysis.

Authors:  Kirk M Chan-Tack; Graeme Forrest
Journal:  Scand J Infect Dis       Date:  2005

3.  West Nile Virus Myelitis.

Authors:  A Ohry; H Karpin; D Yoeli; A Lazari; Y Lerman
Journal:  Spinal Cord       Date:  2001-12       Impact factor: 2.772

4.  Acute flaccid paralysis syndrome associated with West Nile virus infection--Mississippi and Louisiana, July-August 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-09-20       Impact factor: 17.586

5.  West Nile virus activity--United States, 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-07-04       Impact factor: 17.586

6.  Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice.

Authors:  David Ben-Nathan; Shlomo Lustig; Guy Tam; Shahar Robinzon; Shraga Segal; Bracha Rager-Zisman
Journal:  J Infect Dis       Date:  2003-06-23       Impact factor: 5.226

7.  Intrathecal tetanus immunoglobulins in the management of tetanus.

Authors:  M G Geeta; P Krishnakumar; Lulu Mathews
Journal:  Indian J Pediatr       Date:  2007-01       Impact factor: 5.319

8.  Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000.

Authors:  D Weiss; D Carr; J Kellachan; C Tan; M Phillips; E Bresnitz; M Layton
Journal:  Emerg Infect Dis       Date:  2001 Jul-Aug       Impact factor: 6.883

9.  Treatment of West Nile virus encephalitis with intravenous immunoglobulin.

Authors:  Z Shimoni; M J Niven; S Pitlick; S Bulvik
Journal:  Emerg Infect Dis       Date:  2001 Jul-Aug       Impact factor: 6.883

10.  Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection.

Authors:  David Ben-Nathan; Orly Gershoni-Yahalom; Itzchak Samina; Yevgeny Khinich; Israel Nur; Orgad Laub; Ahuva Gottreich; Michael Simanov; Angel Porgador; Bracha Rager-Zisman; Nadav Orr
Journal:  BMC Infect Dis       Date:  2009-02-17       Impact factor: 3.090
View more
  10 in total

1.  West nile virus.

Authors:  Georg Pauli; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-07-04       Impact factor: 3.747

2.  An Atypical Presentation of West Nile Virus With Successful Treatment After Plasma Exchange and Intravenous Immunoglobulin.

Authors:  Kevin Malone; Rahul Abraham; Grace Mccurdy; Vishal Devarkondal; Christopher M Stevens
Journal:  Cureus       Date:  2022-04-10

3.  The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys.

Authors:  Yuko Muraki; Takeshi Fujita; Masaaki Matsuura; Isao Fuke; Sadao Manabe; Toyokazu Ishikawa; Yoshinobu Okuno; Kouichi Morita
Journal:  Virol J       Date:  2015-04-09       Impact factor: 4.099

4.  May early intervention with high dose intravenous immunoglobulin pose a potentially successful treatment for severe cases of tick-borne encephalitis?

Authors:  Daniel Růžek; Gerhard Dobler; Hans Helmut Niller
Journal:  BMC Infect Dis       Date:  2013-07-03       Impact factor: 3.090

Review 5.  Recent advances in Japanese encephalitis.

Authors:  Anirban Basu; Kallol Dutta
Journal:  F1000Res       Date:  2017-03-13

6.  West Nile virus encephalitis in GATA2 deficiency.

Authors:  Jaime S Rosa; Shanthi Kappagoda; Amy P Hsu; Joie Davis; Steven M Holland; Anne Y Liu
Journal:  Allergy Asthma Clin Immunol       Date:  2019-01-24       Impact factor: 3.406

7.  A Potential Role for Substance P in West Nile Virus Neuropathogenesis.

Authors:  Shannon E Ronca; Sarah M Gunter; Rebecca Berry Kairis; Allison Lino; Jonathan Romero; Robia G Pautler; Alan Nimmo; Kristy O Murray
Journal:  Viruses       Date:  2022-09-04       Impact factor: 5.818

8.  Clinical Outcomes of Japanese Encephalitis after Combination Treatment of Immunoglobulin, Ribavirin, and Interferon-α2b.

Authors:  Hyoshin Son; Jun Sang Sunwoo; Sang Kun Lee; Kon Chu; Soon Tae Lee
Journal:  J Clin Neurol       Date:  2021-07       Impact factor: 3.077

Review 9.  How to approach and treat viral infections in ICU patients.

Authors:  Theodoros Kelesidis; Ioannis Mastoris; Aliki Metsini; Sotirios Tsiodras
Journal:  BMC Infect Dis       Date:  2014-11-28       Impact factor: 3.667

Review 10.  Enterovirus D68 - The New Polio?

Authors:  Hayley Cassidy; Randy Poelman; Marjolein Knoester; Coretta C Van Leer-Buter; Hubert G M Niesters
Journal:  Front Microbiol       Date:  2018-11-13       Impact factor: 5.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.